Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer
- PMID: 21794974
- DOI: 10.1016/j.eururo.2011.07.010
Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer
Abstract
Background: Cigarette smoking is the most well-established risk factor for developing bladder cancer.
Objective: To investigate the role of smoking status on the clinical outcome of patients with non-muscle-invasive bladder cancer.
Design, setting, and participants: Data obtained during a prospective phase 3 study with three schedules of epirubicin were used for statistical analysis. Smoking status (obtained when entering the study), other prognostic variables, and clinical outcome measures of 718 patients were analyzed. Mean follow-up was 2.5 yr.
Measurements: The primary outcome measure was recurrence-free survival (RFS).
Results and limitations: Demographics were similar for nonsmokers versus ex-smokers and current smokers, except for gender (p<0.001) and grade (p=0.022). In univariate analyses, RFS was significantly shorter in male patients (p=0.020), in patients with a history of recurrences (p<0.003), in patients with multiple tumors (p<0.004), in patients with a history of intravesical therapy (p=0.037), and in ex-smokers and current smokers (p=0.005). In multivariate analyses, a history of recurrences, multiplicity, and smoking status remained significant factors for predicting RFS. Gender and initial therapy were no longer a significant influence on RFS. Because progression was uncommon (n=25) and follow-up was short and focused only on recurrences, no conclusion can be drawn on progression-free survival. A limitation of the study were the questionnaires. They were only used when entering the study, and there were no questions about passive smoking and other causal factors.
Conclusions: In this prospective study, the significance of known factors (history of recurrences and number of tumors) in predicting RFS was confirmed. Another significant factor that appears to predict RFS is smoking status: ex-smokers and current smokers had a significantly shorter RFS compared with nonsmokers.
Copyright © 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma.Urology. 2013 Feb;81(2):277-81. doi: 10.1016/j.urology.2012.09.040. Urology. 2013. PMID: 23374781
-
Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study.Eur Urol. 2009 Apr;55(4):773-80. doi: 10.1016/j.eururo.2009.01.006. Epub 2009 Jan 13. Eur Urol. 2009. PMID: 19153001 Clinical Trial.
-
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer.BJU Int. 2007 Aug;100(2):281-6; discussion 286. doi: 10.1111/j.1464-410X.2007.06873.x. Epub 2007 Apr 5. BJU Int. 2007. PMID: 17419696
-
Smoking and smoking cessation effects on oncological outcomes in nonmuscle invasive bladder cancer.Curr Opin Urol. 2014 Sep;24(5):492-9. doi: 10.1097/MOU.0000000000000079. Curr Opin Urol. 2014. PMID: 24887046 Review.
-
[Gender disparities in urologic cancers].Rev Med Suisse. 2015 Dec 2;11(497):2276-8, 2280. Rev Med Suisse. 2015. PMID: 26785525 Review. French.
Cited by
-
A chronic obstructive pulmonary disease negatively influences the prognosis of patients with bladder urothelial carcinoma via hypoxia inducible factor-1α.Int J Clin Exp Med. 2014 Oct 15;7(10):3344-53. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25419367 Free PMC article.
-
Efficacy and safety of transurethral resection of bladder tumour combined with chemotherapy and immunotherapy in bladder-sparing therapy in patients with T1 high-grade or T2 bladder cancer: a protocol for a randomized controlled trial.BMC Cancer. 2023 Apr 6;23(1):320. doi: 10.1186/s12885-023-10798-2. BMC Cancer. 2023. PMID: 37024824 Free PMC article.
-
Smoking-related bladder cancer burden from 1990 to 2021: An age-period-cohort analysis of the global burden of disease study.Tob Induc Dis. 2025 Jun 12;23. doi: 10.18332/tid/204744. eCollection 2025. Tob Induc Dis. 2025. PMID: 40510732 Free PMC article.
-
The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study.Cancer Causes Control. 2018 Jul;29(7):675-683. doi: 10.1007/s10552-018-1046-8. Epub 2018 May 30. Cancer Causes Control. 2018. PMID: 29846846 Free PMC article.
-
ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer.World J Urol. 2019 Jan;37(1):51-60. doi: 10.1007/s00345-018-2438-9. Epub 2018 Aug 14. World J Urol. 2019. PMID: 30109483 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical